Pharmaceuticals
Bayer and the American Academy of Family Physicians (AAFP) launch Research and Advancement in Cardiorenal Health (REACH) Awards
Whippany, NJ, July 1, 2026
Bayer and AAFP are proud to announce the launch of a new investigator sponsorship program — the REsearch and Advancement in Cardiorenal Health (REACH) Awards.
Through this program, grants will be available to eligible healthcare professionals, clinical researchers, fellows, scientists, and epidemiologists in the United States whose work focuses on cardiovascular, kidney, and metabolic (CKM) health.
Key Facts
- Each grant is valued at up to $20,000.
- Applicants are encouraged to download Letter of Intent (LOI) proposals from www.REACHAwards.bayer.com.
- Applicants should email completed LOI proposals to REACHAwards@porterhousemedical.com.
- Application deadline is August 16, 2026.
Why This Matters
“Primary care providers play a critical role in identifying and managing CKM conditions, and we look forward to supporting these primary care providers’ investigations via the REACH Awards,” said Dr. Robert Perkins, Vice President and Head of U.S. Medical Affairs for Cardiovascular and Renal Care, Bayer Pharmaceuticals. “This collaboration between Bayer and AAFP is intended to support scientific inquiry and increase awareness of opportunities to advance CKM research within the primary care community.”
AAFP Executive Commentary
“Our partnership with Bayer supports research focused on underserved populations, the advancement of patient care, and educational efforts for our family physicians,” said Dr. Margot L. Savoy, Chief Medical Officer and Senior Vice President of Education, Inclusiveness, and Physician Well-Being at AAFP. “Family physicians are the cornerstone of health and are ideally positioned to support early identification and management of CKM conditions.”
About the American Academy of Family Physicians
The AAFP is the largest national association of family physicians, representing 124,500 physicians and medical students. Family medicine’s cornerstone is an ongoing, personal patient-physician relationship focused on impactful care for people of all ages, races and genders across all medical conditions. The AAFP supports every stage of a family physician's career and provides evidence-based resources, advocacy and community to empower family medicine. To learn more, visit aafp.org. For information about health care, medical conditions, and wellness, please visit the AAFP’s patient education website, familydoctor.org.
About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all, Hunger for none,” the company’s products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2025, the Group employed around 88,000 people and had sales of 45.6 billion euros. R&D expenses amounted to 5.8 billion euros.
Forward-Looking Statements from Bayer
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties, and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company, and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. Bayer AG is a holding company with operating subsidiaries worldwide. References to “Bayer” or “the company” herein may refer to one or more subsidiaries as context requires.